Lineage Cell Therapeutics (LCTX) Earnings Date & Reports

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LCTX is expected to report earnings to fall 33.33% to -1 cents per share on August 06

Lineage Cell Therapeutics LCTX Stock Earnings Reports

Q2'26

Est.

$-0.02

Q1'26

Missed

by $0.02

Q4'25

Beat

by $0.05

Q3'25

Missed

by $0.11

Q2'25

Missed

by $0.10

The last earnings report on May 12 showed earnings per share of -2 cents, missing the estimate of 0 cents. With 400.52K shares outstanding, the current market capitalization sits at 306.64M.

View a ticker or compare two or three

Compare

LCTX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for LCTX